ESMO 2019: Industry Participation

ESMO 2019, the world's premier congress in medical oncology will be taking place in Barcelona from the 27 September - 1 October 2019. 

The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.

This is the ultimate goal of ESMO 2019 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO 2019 Congress

  • 27940 participants, 137 countries
  • 7366 sqm exhibition space, 195 exhibitors
  • 580 invited speakers
  • 195 sessions ESMO, 15 sessions EONS
  • 3352 submitted abstracts

How can I participate in 2019? 

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress. 

Contact the  ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

We gratefully acknowledge the valuable contribution of the following organisations in the ESMO 2019 Congress through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (as of March 2019).

Companies
  • Abbvie
  • Accord Healthcare
  • Advanced Accelerator Applications, a Novartis company
  • AMGEN (Europe) GmbH
  • Amoy Diagnostics Co., Ltd
  • Apogenix AG
  • Astellas Pharma Europe Ltd.
  • AstraZeneca
  • Bayer
  • BeiGene, Ltd.
  • Biocartis
  • BMJ
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Caris Life Sciences
  • Catalysis S.L.
  • Celgene
  • Celltrion Healthcare Co., Ltd.
  • Clovis Oncology
  • Covance, Inc.
  • Daiichi Sankyo
  • ECS Progastrin SA
  • Eisai Europe Ltd
  • Elsevier B.V.
  • EUSA Pharma (UK) Ltd
  • Exelixis
  • F.Hoffmann-La Roche AG
  • Fresenius Kabi
  • Frontiers
  • Genmab
  • Genomic Health International Sarl
  • GSK
  • HalioDx
  • Helsinn Healthcare
  • IBM Watson Health
  • Illumina
  • Incyte Biosciences International Sarl
  • Iovance Biotherapeutics
  • Ipsen
  • IQVIA Biotech
  • ITM Isotopen Technologien Muenchen AG
  • JAMA
  • Janssen Oncology
  • Karger Publishers
  • LeCancer.fr
  • Life Technologies, Ltd.
  • Lilly
  • Loxo Oncology, Inc.
  • medac GmbH
  • Medscape Oncology
  • Menarini Silicon Biosystems
  • Merck
  • MSD
  • NanoString Technologies
  • National Comprehensive Cancer Network (NCCN)
  • NEJM Group
  • Novartis Oncology
  • Nutricia Oncology
  • OncoDNA S.A.
  • Oxford University Press
  • Personal Genome Diagnostics
  • Pfizer Oncology
  • Pharma Mar
  • Philips Molecular Pathway Dx
  • Pierre Fabre Oncology
  • Precision for Medicine, Oncology and Rare Disease
  • prIME Oncology
  • Samsung Bioepis Co., Ltd.
  • Sanofi Genzyme
  • Seattle Genetics
  • Servier
  • Sotio a.s.
  • Springer Healthcare
  • Sysmex Inostics GmbH
  • Takeda Oncology
  • Taylor & Francis
  • Tesaro
  • The Video Journal of Oncology
  • Thermo Fisher Scientific
  • Varian Medical Systems
  • WeHealth by Servier
  • Wisepress Ltd